Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;51:821-822
Published online before print February 11, 2008, doi: 10.1161/HYPERTENSIONAHA.107.103234
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
51/4/821    most recent
HYPERTENSIONAHA.107.103234v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Struijker-Boudier, H. A.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Struijker-Boudier, H. A.J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*High Blood Pressure
*Retinal Disorders
Related Collections
Right arrow Peripheral vascular disease
Right arrow Clinical Studies
Right arrow Other Vascular biology
Right arrowRelated Article

(Hypertension. 2008;51:821.)
© 2008 American Heart Association, Inc.


Editorial Commentaries

Retinal Microcirculation and Early Mechanisms of Hypertension

Harry A.J. Struijker-Boudier

From the Department of Pharmacology and Toxicology, Cardiovascular Research Institute Maastricht, The Netherlands.

Correspondence to Harry A.J. Struijker-Boudier, Department of Pharmacology and Toxicology, Cardiovascular Research Institute Maastricht, P.O. Box 616, 6200 MD Maastricht, The Netherlands. E-mail h.struijkerboudier@farmaco.unimaas.nl


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

The microcirculation plays a critical role in the pathophysiology of hypertension.1,2 The increase in peripheral resistance underlying the raised blood pressure is localized primarily in small arteries (diameter 150 to 300 µm) and arterioles (diameter 10 to 150 µm). The rise in blood pressure causes a further narrowing of small arteries and rarefaction of capillaries and precapillary arterioles, thus creating a vicious cycle. This cycle has been well documented in several animal models of hypertension. However, it has been more difficult to grasp the complete picture in humans, because of technical difficulties to evaluate the microcirculation in vivo. The study of small arteries in humans is based on biopsies usually taken from subcutaneous fat tissue. Using this approach Rizzoni et al3,4 were able to show that small artery narrowing predicts the prevalence of cardiovascular complications in both normotensive and hypertensive individuals. Capillary rarefaction has been assessed in humans using in vivo capillaroscopy of the nailfold microvasculature. The majority of these studies support the hypothesis of capillary rarefaction as an early hallmark of hypertension.1,5,6 In the last few years, advances in retinal photography and computing technologies have enabled objective measurement of small artery and arteriolar vessel size from digital retinal images. Several large population-based studies have applied this approach to quantitatively determine retinal vessel diameters and have documented a consistent association between elevated blood pressure and narrowed retinal arterioles.7–9 Similar studies also indicated that retinal arteriolar narrowing predicts the future blood pressure elevation in previously normotensive persons.10–12

The paper by Liew . . . [Full Text of this Article]


Related Article:

Low Birthweight Is Associated With Narrower Arterioles in Adults
Gerald Liew, Jie Jin Wang, Bruce B. Duncan, Ronald Klein, A. Richey Sharrett, Frederick Brancati, Hsin-Chieh Yeh, Paul Mitchell, Tien Y. Wong for the Atherosclerosis Risk in Communities Study
Hypertension 2008 51: 933-938. [Abstract] [Full Text] [PDF]